Comments on: Panchakarma and Inflammatory Markers: What CRP, ESR, and IL-6 Studies Show

By: Jason Miller

Jason Miller — Tue, 15 Sep 2026 13:53:39 +0000

For anyone considering Panchakarma, it makes sense to view the biomarker data as encouraging but not definitive proof of causation

By: Rachel Adams

Rachel Adams — Mon, 07 Sep 2026 11:14:42 +0000

A limitation highlighted is the short follow up period, making it hard to tell if the marker reductions last months or years

By: Linda Martin

Linda Martin — Sun, 06 Sep 2026 20:45:53 +0000

refreshing to see a Panchakarma article that actually engages with the biomarker literature rather than just repeating classical claims. the IL-6 data especially — that’s a more specific inflammation signal than CRP and harder to dismiss. tbh

By: Emily Foster

Emily Foster — Mon, 31 Aug 2026 03:35:08 +0000

I find it interesting that the Maharishi study didn’t measure CRP directly but still linked toxin removal to possible anti inflammatory effects

By: Brian Adams

Brian Adams — Wed, 26 Aug 2026 10:46:34 +0000

panchakarma sounds serious when you connect it with markers. pls mention who should avoid it during flare ups

By: Sarah Thompson

Sarah Thompson — Sun, 23 Aug 2026 10:10:38 +0000

One practical takeaway is that researchers should standardize the Panchakarma protocol before trying to isolate its effect on biomarkers like CRP

By: Smita Singh

Smita Singh — Sat, 22 Aug 2026 20:25:54 +0000

my experience with a 5-day Panchakarma last winter was that fatigue dropped noticeably by day 3. I didn’t get markers tested but this article makes me wish I had — would have been interesting to have that baseline and post-treatment CRP data in hand.

By: Tim Lee

Tim Lee — Fri, 21 Aug 2026 21:12:31 +0000

i get the idea, but IL-6 is not something normal clinics test here. ESR is easier for regular people

By: Vikram Singh

Vikram Singh — Mon, 17 Aug 2026 22:42:47 +0000

chronic sinusitis aside, the Nasya procedure mentioned briefly in this article is the one I’d most want to see studied separately for inflammatory markers. it seems mechanistically different from Virechana or Basti and lumping them together feels like it loses important detail.

By: Matthew Green

Matthew Green — Sat, 15 Aug 2026 11:02:38 +0000

The article notes that Basti procedures showed a roughly thirty percent lowering of ESR in osteoarthritis patients, which lines up with the traditional claim of joint relief